NSE · AI Signal & Stock Analysis · Neutral
As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for GLAXO is Neutral → (mild move); technical trend raise-2026-07-09; trading at ₹2,470.00 (-3.24% today); neutral (RSI 57).
Data as of Aug 14 2026, 6:50 PM. Informational analytics only — not investment advice.
| AI signal | Neutral → · Mild move |
|---|---|
| Technical trend | RAISE-2026-07-09 |
| Price | ₹2,470.00 |
| Change today | -3.24% |
| RSI (14) | 56.70 |
| Relative volume | 0.16 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹45,550 Cr |
| P/E | 42.71 |
| Cap category | Large Cap |
| 52-week high | -20.8% away |
| 52-week low | +17.4% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - General |
As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for GLAXO (GlaxoSmithKline Pharmaceuticals Limited) is Neutral with a mild move, and its technical trend is raise-2026-07-09. The composite score and full factor breakdown are available to signed-in members.
GLAXO's RSI is neutral (RSI 57). A reading above 70 is typically overbought and below 30 oversold.
GLAXO is trading about 21% below its 52-week high and 17% above its 52-week low as of Aug 14 2026, 6:50 PM.
GLAXO's market capitalisation is ₹45,550 Cr as of Aug 14 2026, 6:50 PM.
GLAXO is classified under Drug Manufacturers - General in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 6:50 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.